Pacira BioSciences Newsroom

Raymond James Maintains Pacira BioSciences(PCRX.US) With Hold Rating

Futu News09:32 · Ratings

Sector Update: Health Care Stocks Weaker Late Afternoon

MT Newswires04:58

TD Synnex, Walgreens, Savers Value Village And Other Big Stocks Moving Higher On Friday

Benzinga01:26

Pacira Biosciences Shares Are Trading Higher After the Company Reported a Preliminary Year-over-year Increase in FY25 Revenue.

BenzingaJan 10 22:09

Express News | Pacira Biosciences: Prelim Q4 Exparel Net Product Sales of $147.7 Mln

BreakingsJan 10 21:02

Express News | Pacira Biosciences: Sees Double-Digit Compounded Annual Growth Rate in Product Revenue by 2030

BreakingsJan 10 21:01

Pacira Announces New Five-Year Objectives to Accelerate Transition Into an Innovative Biopharmaceutical Organization

GlobeNewswireJan 10 21:00

Express News | Pacira Biosciences FY Revenue USD 701 Million Vs. IBES Estimate USD 694.6 Million

BreakingsJan 10 21:00

FDA Clears PCRX's New Iovera Smart Tip for Expanded Use in Pain Relief

Zacks Jan 8 23:35

Pacira BioSciences Secures FDA Approval For New Iovera SmartTip to Manage Chronic Low Back Pain

BenzingaJan 8 00:49

Express News | Pacira Biosciences Receives FDA 510K Clearance for New Iovera° Smarttip to Manage Chronic Low Back Pain via Long-Lasting Medial Branch Nerve Block

BreakingsJan 7 21:00

RBC Raises Price Target on Pacira Biosciences to $18 From $16, Keeps Sector Perform Rating

MT NewswiresJan 7 20:49 · Ratings

Pacira BioSciences to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Pacira BioSciencesJan 2 13:00

VectorY Strengthens Leadership Team With Appointment of Jim Scibetta as New CEO

BusinesswireDec 16, 2024 20:00

Express News | Doma Perpetual: Urges Pacira to Immediately Commence Stock Tender Offer for 10 Mln Shares Using Its Substantial Cash on Hand

BreakingsDec 11, 2024 21:06

Express News | Doma Perpetual: Believes Pacira Biosciences' Stock Is "Grossly Undervalued"

BreakingsDec 11, 2024 21:06

Express News | Doma Perpetual Capital Management Announces Intent to Nominate Four Highly Qualified, Independent Director Candidates at 2025 Annual Meeting of Pacira Biosciences, Inc.

BreakingsDec 11, 2024 21:05

DOMA Perpetual Capital Management Announces Intent to Nominate Four Highly Qualified, Independent Director Candidates at 2025 Annual Meeting of Pacira BioSciences, Inc.

PR NewswireDec 11, 2024 21:05

Pacira BioSciences (NASDAQ:PCRX) Shareholders Are up 7.2% This Past Week, but Still in the Red Over the Last Three Years

Simply Wall StDec 11, 2024 03:28

Press Release: Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Dow JonesDec 6, 2024 21:00